We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microbiome Composition Predicts Outcome Among Stem Cell Transplant Patients

By LabMedica International staff writers
Posted on 12 Mar 2020
Allogeneic hematopoietic stem cell transplants are common among patients with blood cancers, and while they may cure the disease, such transplants can also lead to complications such as graft-versus-host disease and infections.

The intestinal microbiota play a role in host physiology. More...
Patients undergoing allogeneic hematopoietic-cell transplantation have microbiota disruption that is characterized by expansions of potentially pathogenic bacteria and loss of alpha diversity which is a variable that reflects the number of unique bacterial taxa present and their relative frequencies.

A large team of international scientists led by the Memorial Sloan-Kettering Cancer Center group (MSKCC, New York, NY, USA) prospectively collected a median four stool samples from 1,362 patients from four centers undergoing allogeneic hematopoietic stem cell transplants. Most patients were being treated for acute leukemia, though others had myeloma or aplastic anemia. The team used 16S ribosomal RNA gene sequencing, and they characterized patients' gut microbiomes before and after transplantation. Patients at all four centers exhibited a loss of microbial diversity during the transplant time frame.

The investigators divided patients from MSKCC into high and low diversity groups; they noticed that higher gut microbiome diversity was associated with a lower risk of death, including transplant-related death. This association held even after they accounted for patients' age, how intense patients' pre-transplant conditioning regime was, and graft source. Similarly, higher gut microbiome diversity was associated with a lower risk of death among patients from the three other medical centers combined.

Lower-diversity microbiomes were often marked by an overabundance of certain bacteria. In particular, there was an enrichment of Enterococcus, Klebsiella, Escherichia, Staphylococcus, and Streptococcus among these samples. The scientists noted that higher levels of Enterococcus has previously been linked to an increased risk of vancomycin-resistant enterococcal bacteremia and graft-versus-host disease. But even before undergoing the transplant, patients had less diverse gut microbiomes than healthy individuals. The initial 600 fecal samples the team collected from patients at all four centers had less diversity than samples from healthy volunteers, indicating that the patients arrive for treatment with microbiomes that already differed from those of healthy individuals.

The authors concluded that their study defines opportunities for rational interventions to restore integrity to the intestinal microbiota, such as with fecal microbiota replacement or other strategies which could also be evaluated in clinical settings beyond allogeneic hematopoietic-cell transplantation. The study was published on February 27, 2020 in the journal The New England Journal of Medicine.

Related Links:
Memorial Sloan-Kettering Cancer Center


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PSA Assay
CanAg PSA EIA
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.